IceCure Medical, Ltd. (ICCM) - Aggregate Business Assets

ICCM (IceCure Medical Ltd) - company brandmark

The market trend for IceCure Medical (ICCM) shown on this price chart reflects the dynamics of total assets, which currently stand at 14.15. IceCure Medical Ltd minimizes surgical risks by freezing neoplasms in the kidneys and breasts. Business growth is driven by the expansion of ProSense systems as a minimally invasive therapy method. Strict FDA regulations and exclusive cryodestruction patents ensure a high barrier to entry.

ICCM (icecure-medical.com) Company Total Assets history from 07/04/2022 to 10/30/2026

Financial and market metric breakdowns for icecure-medical.com (ICCM)

- price and consensus price forecast:
Stock Quotes IceCure Medical|ICCM - Consensus Target
- market capitalization indicators:
Market Value IceCure Medical Ltd|ICCM - Enterprise Value
- balance sheet net asset value indicators:
Accounting Value of a Share IceCure Medical|ICCM - Book Capitalization|Market-to-Book Ratio icecure-medical.com|ICCM - Aggregate Company Assets
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio IceCure Medical Ltd|ICCM - Long-Term Debt to Capital|Short-Term Debt to Capital IceCure Medical|ICCM - Company Debts|Debts to Book Capitalization Ratio IceCure Medical Ltd|ICCM - Company Long-Term Debts|Short-Term Debt IceCure Medical|Quick Ratio icecure-medical.com
- net income and valuation multiples indicators:
ICCM - Net Income
Basic company analysis:IceCure Medical, Ltd. ICCM
Manufactured products of icecure-medical.com

IceCure Medical Ltd (ICCM) management's drive toward international expansion and equipment certification is reflected in the trends of consolidated assets, demonstrating a resource base for scaling. This metric, reverse-calculated via ROA, aggregates the value of all controlled resources funded by equity and debt, allowing investors to assess operational scale and the risk of inefficient capital allocation.

Direct competitors

Cumulative Company Assets dexcom.com|Cumulative Company Assets PEN|NOVT (Novanta Inc) - Aggregate Business Assets|Company Total Assets HAE|INSP (Inspire Medical Systems Inc) - Aggregate Asset Value|Company Total Assets PRCT (PROCEPT BioRobotics)|conmed.com (CNMD) - Company Assets|PLSE - Aggregate Company Assets|Aggregate Asset Value INMD (InMode Ltd)|PMI: Company Total Assets|Surmodics Inc. (SRDX) - Company Total Assets|Aggregate Company Assets Senseonics Holdings Inc|neuropace.com - Total Asset Value of Company|Company Total Assets TCMD|SNWV - Company Assets|Outset - Cumulative Company Assets|Company Total Assets SmartVest ELMD|LNSR: Cumulative Company Assets|avitamedical.com - Aggregate Business Assets|PROF: Company Total Assets|BDMD - Company Total Asset Base|EDAP (EDAP TMS SA) - Company Total Assets|Cumulative Company Assets Bovie Medical (APYX)|Cumulative Company Assets LUNG (Pulmonx Corporation)|TELA (telabio.com) - Aggregate Asset Value|Aggregate Company Assets CytoSorbents Corporation CTSO|SRTS - Cumulative Company Assets|Zynex Inc - Company Total Assets|Company Assets electroCore, Inc.|RBOT: Company Total Assets|Total Business Assets IINN|ICU (SeaStar Medical) - Company Total Assets|IRIDEX Corp. (IRIX) - Company Total Asset Base|Company Total Assets INBS|Cumulative Company Assets beyondair.net XAIR|Company Total Assets PFSA (Profusa Inc)|Company Total Assets STRATA Skin Sciences Inc. SSKN|GCTK - Aggregate Company Assets|NAOV: Aggregate Company Assets|VERO (Venus Concept Corp) - Cumulative Company Assets|Nuwellis Corp - Aggregate Asset Value|AEMD (Aethlon Medical) - Company Total Assets|Company Assets TransEnterix ASXC|Aggregate Company Assets Avinger (AVGR)|BioSig Technologies (BSGM) - Company Balance Sheet Assets|Cutera, Inc - Cumulative Company Assets|Company Total Assets Know Labs Corporation KNW|Inari Medical, Inc. - Company Total Assets|Company Total Asset Base nevro.com NVRO|reshapelifesciences.com (RSLS) - Aggregate Company Assets|Total Asset Value of Company SILK (Silk Road Medical, Inc.)